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Backgrounds: The associations between the polymorphisms of interleukin-8 (IL-8) gene and gastric carcinogenesis
have been extensively investigated in recent years. However, the results remain conflicting rather than conclusive.
Methods: A meta-analysis of 18 eligible studies was performed to evaluate the association of IL-8 -251A > T
polymorphism with risk of gastric carcinogenesis. A systematic literature search of MEDLINE, Embase, and Web of
Science, CNKI databases was conducted. Statistical analysis was performed by using the Revman 5.1 software and
the Stata 12.0 software.
Results: Of the 293 unique studies identified using our search criteria, 18 studies fulfilled our inclusion criteria and
were included in the meta-analysis. These studies cumulatively reported 5,321 cases and 6,465 controls. The
combined results based on all studies showed that the IL-8 -251A > T polymorphism was associated with the risk of
gastric carciongenesis (A vs. T: OR: 1.14 [1.02, 1.26], P = 0.02), especially gastric cancer (A vs. T: OR: 1.15 [1.03, 1.29],
P = 0.02), but not associated with the risk of precancerous lesion (A vs. T: OR: 1.09 [0.99, 1.20], P = 0.08). Analysis
stratified by ethnicity may seem that IL-8 -251A > T polymorphism was susceptible to gastric cancer in Asian
population, but not in Caucasian population.
Conclusions: Our meta-analysis results provide evidence that IL-8 -251A > T polymorphism is significantly
associated with increased risk of gastric carcinogenesis in Asian population, particularly in gastric cancer. Further
large and well-designed studies are required to confirm this conclusion.
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Although the incidence of gastric cancer has recently de-
clined in several countries, it is still a serious health prob-
lem and remains the world’s fourth common malignancy
and the second leading cause of cancer death [1-3]. Cur-
rently, many epidemiologic studies have demonstrated
that gastric cancer has a multifactorial etiology and is co-
modulated by different factors including Helicobacter
pylori infection, life style, socioeconomic status, and en-
vironmental factors [4]. In addition, genetic factors are
increasingly recognized as major contributors to gas-
tric cancer risk [5], although not yet well understood.
Perhaps, the genes involved in gastric cancer mutated* Correspondence: dayecheng_cmu@163.com
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reproduction in any medium, provided the orwhich intimately control cell growth and apoptosis,
allowing cells to acquire the ability to invade and me-
tastasize. Therefore, identification of biomarkers sig-
nificantly related to development and progress of
gastric cancer and elucidation of the molecular mecha-
nisms for cancer prevention and control strategy are
essential for better gastric treatment.
Chemotactic cytokines, produced by tumor and endo-
thelial cells, could play an important role in cancer, such
as increasing angiogenesis, stimulating tumor progression,
enhancing tumor cell migration, and facilitating evasion
of immune surveillance [6,7]. As a member of the chemo-
kine family, interleukin-8 (IL-8) is well known for its
leukocyte chemotactic properties and its tumorigenic and
proangiogenic activities [8]. In vivo and in vitro experi-
ments in melanoma [9], as well as breast [10], ovarianLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[14] have shown a direct correlation between IL-8
levels and tumor progression [8]. Moreover, it has
been reported that expression of IL-8 in gastric cancer
specimens was significantly higher than in correspond-
ing normal gastric mucosa [15], and is associated with
adhesion, migration and invasion in gastric cancer
[15]. Therefore, it is reasonable to deduce that IL-8
plays a certain role in the formation and progression
of gastric tumor.
IL-8 gene, which is located on chromosome 4q12-21,
contains four exons and three introns, and exhibits
functional polymorphisms, fifteen of which have been
characterized [16]. Among these polymorphisms the
presence of IL-8-251 A > T in the promoter region ex-
erts the greatest influence on IL-8 production and is
associated with the risk of prostate [17], breast [18],
oral [19], colorectal cancer [20] and Kaposi’s sarcoma
[21]. To better understand this issue, we performed an
updated systemic review and meta-analysis of all eli-
gible case–control studies to provide insights into the
association between IL-8 -251A > T polymorphism and
susceptibility to gastric carcinogenesis, which may pro-
mote our understanding of the exact role of IL-8 gene
in the etiology of gastric cancer.
Results
Search results
Of the 293 unique studies identified using our search
criteria, 18 case–control studies fulfilled our inclusion
criteria and were included in the meta-analysis [22-39].
These studies cumulatively reported 5,321 cases and
6,465 controls. The publication year of involved studies
ranged from 2004 to 2012. Detailed search steps were
described in Figure 1.Figure 1 Flow chart of study selection. (CNKI, Chinese National
Knowledge Infrastructure).The characteristics of included studies
The main features of the studies included in the meta-
analysis were shown in Table 1. Among these studies,
six studies were performed in Caucasian populations
[22-25,31,32], eleven studies in Asian populations
[26-29,33-35,37-39], and one study in mixed popula-
tion [36]. Ten studies used hospital-based controls,
while the other eight studies used population-based con-
trols (community populations). Most studies indicate that
the distribution of genotypes in controls was consistent
with Hardy–Weinberg equilibrium (HWE), and the sub-
jects of controls were matched for age and gender. All
cases were confirmed histologically or pathologically.
Quantitative data synthesis
Table 2 showed the summary odds ratio (OR) relating IL-
8-251 A > T to gastric carcinogenesis risk based on 5,321
cases and 6,465 controls in all 18 studies.
Overall analysis
Eighteen studies involved the correlations between IL-8-
251 A > T polymorphism and gastric carcinogenesis. The
heterogeneity obviously existed under most genetic mo-
dels, which might be a result of the difference in ethnicity,
country, source of controls and genotype methods, so ran-
dom effects model was conducted to pool the results. By
allelic comparison, A-allele genotypes were associated
with gastric carcinogenesis, with a pooled OR of 1.14
(95% CI: 1.02–1.26, P = 0.02) (Figure 2). There were also
significant associations in the recessive model (AA +AT
versus TT) (OR = 1.18, 95% CI: 1.02–1.36, P = 0.03), and
homozygous comparison (AA versus TT) (OR = 1.26, 95%
CI: 1.02–1.57, P = 0.04), respectively, but not in the dom-
inant model (AA vs AT + TT) (OR = 1.17, 95% CI = 0.98–
1.38, P = 0.07) and the heterozygous comparison (AT ver-
sus TT) (OR = 1.14, 95% CI: 1.00–1.31, P = 0.05)
(Table 2). In the stratified analysis by ethnicity, we
found that gastric carcinogenesis risk was significant in-
creased in Asian population under allele comparison
(OR = 1.20, 95% CI: 1.06–1.36, P < 0.05), dominant
model (OR = 1.28, 95% CI: 1.02–1.61, P = 0.04), reces-
sive model (OR = 1.26, 95% CI: 1.08–1.47, P < 0.01),
homozygous comparison (OR = 1.40, 95% CI: 1.08–1.83,
P = 0.01), and heterozygous comparison (OR = 1.21,
95% CI: 1.09–1.35, P < 0.01). However, no significant as-
sociation between this polymorphisms and gastric car-
cinogenesis risk was observed in all comparison models
in Caucasians population (Table 2).
Subgroup analysis
In the subgroup analysis, we evaluated the significance in
patients with gastric cancer or precancerous lesion, re-
spectively. In the gastric cancer group, we found that in-
dividuals with A-allele had significantly higher gastric
Table 1 Baseline characteristics of the 18 eligible studies for the analysis of IL-8-251 A > T polymorphism
Studies Year Country Ethnicity Source of controls Number of controls Number of case Genotyping method HWE
Burada F 2012 Romanian Caucasian HB 242 105 Real-time PCR 0.386
Canedo P 2007 Portugal Caucasian PB 693 401 Taqman 0.460
Crusius JB 2008 European Caucasian HB 1139 428 Real-time PCR 0.706
Kamangar F 2006 Finland Caucasian PB 207 112 Taqman 0.055
Kang JM 2009 Korea Asian HB 322 645 RFLP 0.226
Lee WP 2005 Taiwan Asian HB 308 461 RFLP 0.143
Liu J 2009 China Asian HB 137 417 Taqman 0.145
Lu W 2005 China Asian PB 300 250 DHPLC 0.516
Ohyauchi M 2005 Japan Asian PB 346 212 Direct sequence analysis 0.549
Savage SA 2004 Poland Caucasian PB 429 88 SBE 0.885
Savage SA 2006 Poland Caucasian PB 428 287 Taqman or MGB Eclipse 0.391
Shirai K 2005 Japan Asians HB 468 181 RFLP 0.830
Song B 2010 China Asian HB 190 208 RFLP 0.389
Taguchi A 2005 Japan Asian HB 252 611 RFLP 0.994
Vinagre RM 2011 Brazil Mixed HB 103 102 RFLP 0.151
Ye BD 2009 Korea Asian HB 206 399 RFLP 0.553
Zeng ZR 2005 China Asian PB 196 206 PCR-RDB 0.022
Zhang LW 2010 China Asian PB 504 519 PCR-RFLP 0.754
PB, population-based controls; HB, hospital-based controls. HWE, Hardy–Weinberg equilibrium. PCR, polymerase chain reaction; RFLP, restriction fragment length
polymorphism; SBE, single base extension; PCR-RDB, polymerase chain reaction- reverse dot blot.
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(Figure 3). The results also indicated the significant risk
under three models (recessive model: OR = 1.21, 95% CI:
1.03–1.43, P = 0.02; homozygous comparison: OR = 1.29,
95% CI: 1.02–1.62, P = 0.03; heterozygous comparison:
OR = 1.18, 95% CI: 1.01–1.38, P = 0.03), whereas no sig-
nificant risk was observed under dominant model (OR =
1.18, 95% CI: 1.01–1.38, P = 0.03). Moreover, we found
that gastric cancer risk was significant increased in Asian
population under allele comparison (OR = 1.23, 95% CI:
1.07–1.40, P < 0.01), dominant model (OR = 1.28, 95% CI:
1.01–1.63, P = 0.04), recessive model (OR = 1.32, 95%
CI: 1.09–1.59, P < 0.01), homozygous comparison (OR =
1.46, 95% CI: 1.09–1.95, P = 0.01), and heterozygous com-
parison (OR = 1.27, 95% CI: 1.06–1.52, P = 0.01). However,
no significant association between this polymorphisms and
gastric cancer risk was observed in all comparison models
in Caucasians population (Table 2).
The information on the association between IL-8-251
A > T polymorphism and gastric precancerous lesions
was available from four articles evaluated in this study
(Figure 4). No remarkable association was presented be-
tween IL-8-251 A > T polymorphism and the presence
of gastric precancerous lesions under the allele com-
parison (OR = 1.09, 95% CI: 0.99–1.20, P = 0.08), domi-
nant model (OR = 1.15, 95% CI: 0.85–1.56, P = 0.37),
recessive model (OR = 1.21, 95% CI: 0.99–1.49, P = 0.07),
homozygous comparison (OR = 1.27, 95% CI: 0.91–1.76,P = 0.16), and heterozygous comparison(OR = 1.19, 95%
CI: 0.96–1.48, P = 0.11).
Publication bias
Begger’s funnel plot and Egger’s linear regression test
were performed to assess the publication bias of in-
cluded studies. The shapes of the funnel plots seemed
symmetrical in the allele comparison model (P = 0.484)
(Figure 5). Egger’s test also did not show any signifi-
cantly statistical evidence of publication bias under the
allele comparison model (P =0.05), which indicated low
risk of publication bias in this meta-analysis.
Discussion
The pathogenesis of gastric carcinogenesis involves en-
vironmental factors, molecular signaling pathways, and
host genetic factors [40]. The role of cytokine gene
polymorphisms is currently a hot topic in gastric can-
cer research. Genome-wide association studies have
identified several genetic loci associated with suscepti-
bility to gastric carcinogenesis. Recently, a growing
number of studies have suggested that SNPs of IL-8
251 allele, which is located at the promoter sequence
of the IL-8 gene, might be associated with gastric
tumorigenesis [41]. However, the results are contra-
dictory. Hence, it is worth performing a meta-analysis
of all eligible studies to investigate more precise esti-
mation of this specific association.
Table 2 Main results for the IL-8-251 A > T polymorphism with the risk of gastric carcinogenesis based on OR and 95% CI
Genotype comparison OR [95% CI] Z (P value) Heterogeneity of study design Model
χ2 I2
Overall analysis (5,321 cases, 6,465 controls)
A allele vs T allele 1.14 [1.02, 1.26] 2.33 (0.02) 59.55 71% Random
Asian 1.20 [1.06, 1.36] 2.87 (<0.01) 29.42 66% Random
Caucasian 0.95 [0.85, 1.07] 0.87 (0.38) 7.38 32% Random
AA vs AT + TT (dominant model) 1.17 [0.98, 1.38] 1.78 (0.07) 40.15 58% Random
Asian 1.28 [1.02, 1.61] 2.11 (0.04) 24.53 59% Random
Caucasian 0.92 [0.79, 1.08] 1.02 (0.31) 6.42 22% Fixed
AA + AT vs TT (recessive model) 1.18 [1.02, 1.36] 2.21 (0.03) 50.59 66% Random
Asian 1.26 [1.08, 1.47] 2.86 (<0.01) 23.13 57% Random
Caucasian 0.90 [0.78, 1.03] 1.53 (0.13) 5.29 70% Random
AA vs TT (homozygous comparison) 1.26 [1.02, 1.57] 2.10 (0.04) 52.95 6% Fixed
Asian 1.40 [1.08, 1.83] 2.50 (0.01) 27.43 64% Random
Caucasian 0.87 [0.73, 1.05] 1.48 (0.14) 7.62 34% Fixed
AT vs TT (heterozygous comparison) 1.14 [1.00, 1.31] 1.97 (0.05) 39.34 57% Random
Asian 1.21 [1.09, 1.35] 3.55 (<0.01) 18.92 47% Random
Caucasian 0.91 [0.78, 1.05] 1.29 (0.20) 3.64 0% Fixed
Gastric cancer analysis (4,513 cases, 6,465 controls)
A allele vs T allele 1.15 [1.03, 1.29] 2.43 (0.02) 63.29 73% Random
Asian 1.23 [1.07, 1.40] 2.94 (<0.01) 32.40 69% Random
Caucasian 0.95 [0.84, 1.07] 0.85 (0.40) 7.46 33% Random
AA vs AT + TT (dominant model) 1.17 [0.98, 1.39] 1.75 (0.08) 40.38 58% Random
Asian 1.28 [1.01, 1.63] 2.02 (0.04) 25.37 61% Random
Caucasian 0.92 [0.79, 1.09] 0.95 (0.34) 6.31 21% Fixed
AA + AT vs TT (recessive model) 1.21 [1.03, 1.43] 2.36 (0.02) 58.32 71% Random
Asian 1.32 [1.09, 1.59] 2.88 (<0.01) 29.51 66% Random
Caucasian 0.90 [0.78, 1.03] 1.55 (0.12) 5.40 7% Fixed
AA vs TT (homozygous comparison) 1.29 [1.02, 1.62] 2.17 (0.03) 56.20 70% Random
Asian 1.46 [1.09, 1.95] 2.52 (0.01) 30.52 67 Random
Caucasian 0.87 [0.72, 1.05] 1.44 (0.15) 7.65 35 % Fixed
AT vs TT (heterozygous comparison) 1.18 [1.01, 1.38] 2.14 (0.03) 47.23 64% Random
Asian 1.27 [1.06, 1.52] 2.57 (0.01) 25.47 61% Random
Caucasian 0.90 [0.78, 1.05] 1.33 (0.18) 3.68 0% Fixed
Precancerous lesions analysis (808 cases, 1,288 controls)
A allele vs T allele 1.09 [0.99, 1.20] 1.66 (0.08) 2.98 0% Fixed
AA vs AT + TT (dominant model) 1.15 [0.85, 1.56] 0.90 (0.37) 1.92 0% Fixed
AA + AT vs TT (recessive model) 1.21 [0.99, 1.49] 1.84 (0.07) 1.42 0% Fixed
AA vs TT (homozygous comparison) 1.27 [0.91, 1.76] 1.42 (0.16) 2.37 0% Fixed
AT vs TT (heterozygous comparison) 1.19 [0.96, 1.48] 1.59 (0.11) 0.69 0% Fixed
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between the IL-8-251 A > T polymorphism and suscepti-
bility to gastric carcinogenesis in 18 studies. The results
suggested that the AA and AT genotypes of IL-8 -251A >
T polymorphism appears to be associated with an overallincreased risk of gastric carcinogenesis and is discov-
ered as a risk factor of gastric cancer. Subgroup analysis
by ethnicity allowed us to look for potential ethnic dif-
ferences in the association. In the Asian population, the
A-allele was associated with increased risk of gastric
Figure 2 Overall OR for the association between IL-8-251A > T polymorphism and the risk of gastric carcinogenesis (allelic model).
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son, dominant model, recessive model, homozygote com-
parison, and heterozygous comparison. However, for the
Caucasian population, IL-8 -251A > T polymorphism was
not associated with increased risk of gastric carcinogenesis
and gastric cancer. The A allele seemed to be dominant,
but in the precancerous lesion subgroup, no significance
was noted for all models. The possible reason could be
that genetic risk factors differ between gastric cancer and
precancerous lesions.
The IL-8 promoter is estimated to be 1,500 bp. Several re-
ports have shown relationship between IL-8 gene poly-
morphisms and human diseases, and all of them have
focused on the A/T polymorphism at −251 upstream
from the transcriptional start site. IL-8 -251A > T poly-
morphism has been associated with altered transcription
levels of IL-8 by regulating the transcriptional activity ofthe gene and then proved to affect susceptibility to a large
number of diseases. In the present analysis, we found an
overall increase in gastric carcinogenesis of one or two al-
lele variants as compared to wild allele T and homozygous
TT genotype. After stratification into dominant and reces-
sive genetic models, the dominant model (AA vs. AT +
TT) (P = 0.07) and the recessive model (AA +AT vs. TT)
(P = 0.02) both showed increased (1.18 fold) risk of gastric
carcinogenesis. Even though the precise role of IL-8 -
251A > T polymorphism in the development of gastric
carcinogenesis is unknown, a plausible mechanism is that
the mutations of IL-8 gene might increase gene transcrip-
tion after binding to its high affinity cell surface receptor,
which eventually attribute to the correlation between IL-8
and gastric carcinogenesis risk.
In fact, 18 studies were conducted as gastric cancer
subgroup, whereas only 4 studies were conducted as
Figure 3 OR for the association between IL-8-251A > T polymorphism and the risk of gastric cancer (allelic model).
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effect of studies of gastric cancer reported significant asso-
ciation between IL-8 -251A > T polymorphism and risk of
gastric cancer. Moreover, the pooled effect of studies on
patients with precancerous lesions did not show signifi-
cant difference, the reasons for which might be deriving
many elements and multiple mechanisms of gastric can-
cer and precancerous lesion disease. As is known, there
are two mechanisms by which the gastric mucosa pro-
gresses to carcinoma, both starting from chronic gastritis.
One mechanism is via precancerous lesions, such as gas-
tric atrophy, intestinal metaplasia and adenomatous dys-
plasia leading to intestinal-type carcinomas characterized
by glandular formation; the other is via hyperplastic or de
novo changes leading to diffuse-type carcinomas cha-
racterized by isolated cancer cells with an infiltrative
growth. However, our results showed that IL-8 -251A > Tpolymorphism was only associated with gastric cancer
risk, but not with precancerous lesion. Thus, our meta-
analysis suggested that genetic risk factors differ between
gastric cancer and precancerous lesions.
In addition, results differed when stratifying the data by
ethnicity. Associations between IL-8 -251A >T polymorph-
ism and gastric carcinogenesis and gastric cancer were gen-
erally stronger in Asian than Caucasian population. This
discrepancy from our meta-analysis may reflect the com-
plex multifactorial etiology of gastric carcinogenesis.
Our results should be interpreted cautiously since some
limitations exist in this present meta-analysis. First, only
published studies were included in the meta-analysis.
Therefore, the publication bias may have occurred, even
though the use of a statistical test did not show it. Second,
the number of included studies was relatively small with
only about 5,321 cases. Moreover, other clinical factors
Figure 4 OR for the association between IL-8-251A > T
polymorphism and the risk of gastric precancerous lesions
(allelic model).
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study might lead to bias. Determining whether or not
these factors influence the results of this meta-analysis
would need further investigation. Third, the effect from
our meta-analysis could be overestimated because many
studies were retrospective cohort studies which had high
risk of reporting biases. Therefore, more well-designed
studies with large sample sizes are needed to further as-
sess the precise effect of IL-8 -251A > T polymorphism in
gastric carcinogenesis. Finally, the studies included in this
meta-analysis were from different populations, it is pos-
sible that demographic factors can confound our results.
Conclusions
Despite the limitations listed above, our meta-analysis re-
sults provide evidence that IL-8 -251A > T polymorphism
is significantly associated with increased risk of gastric
carcinogenesis, particularly in gastric cancer. Nevertheless,
gastric carcinogenesis is a multifactorial and multistep
process, so our results should be examined cautiously byFigure 5 Begger’s funnel plot of the meta-analysis of IL-8-251A > T po
Each point represents a separate study for the indicated association. Log[O
effect. Note: Funnel plot with pseudo 95% confidence limits was used.an adequately designed prospective studies, and larger
clinical trials with widely accepted assessment methods.
Materials and methods
Search strategy
A systematic literature search of MEDLINE (updated to
June, 2013), Embase (updated to June, 2013), and web of Sci-
ence (updated to June, 2013), and CNKI (Chinese National
Knowledge Infrastructure) databases was conducted by two
study investigators (D.C. and Y. H.) independently for all rele-
vant articles. Key words used in the research included “Inter-
leukin-8”, “IL-8”, “CXCL8”, “gastric cancer”, “stomach cancer”,
“precancerous lesion”, “polymorphism”, “SNP”, “gene va-
riant”, “gene mutation”, and “gastric tumor”.
Inclusion and exclusion criteria
Studies eligible for inclusion in this meta-analysis should
meet the following criteria: (a) case–control studies or co-
hort studies focused on association between IL-8-251 A >
T polymorphism and risk of gastric carcinogenesis; (b) pa-
tients have pathologically or histological confirmed gastric
cancer and/or precancerous lesions; (c) The studies pro-
vided the number of cases and controls for various geno-
types. The exclusion criteria of the meta-analysis were: (a)
animal studies; (b) meta-analyses, letters, reviews or editor-
ial comments; (c) studies with duplicate data or incomplete
date. When an individual author published several articles
obtained from the same patient population, only the newest
or most complete article was included in the analysis.
Data extraction
Information was carefully extracted from all the eligible
publications. The following data were collected from eachlymorphism with gastric carcinogenesis under allele model.
R], natural logarithm of OR. Horizontal line, mean magnitude of the
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http://www.cancerci.com/content/13/1/100study: first author’s name, publication date, country, ethni-
city, source of controls, genotyping method, total numbers
of cases and controls, number of cases and controls for
each IL-8-251 A > T polymorphism, and P value for
HWE. An attempt was made to contact authors if data
presentation was incomplete or if it was necessary to re-
solve an apparent conflict or inconsistency in the article.
Any disagreements were resolved by consensus.
Statistical analysis
Review manager 5.1 program provided by the Cochrane
Library and Stata (Version12.0, Stata Corporation) were
used to perform all the statistical analysis. The associ-
ation was evaluated with the use of the allelic compari-
son (A versus T), as well as the dominant model (AA
versus AT + TT), the recessive model (AA + AT versus
TT), the homozygous comparison (AA versus TT), and
heterozygous comparison (AT versus TT), respectively.
Two models of pooling data for dichotomous outcomes
were conducted: the random-effects model and the
fixed-effects model. The pooled statistical analysis was
calculated using the fixed effects model, but a random-
effect model was performed when the P value of hetero-
geneity test was <0.1 (or I2 > 50%). The odds ratio (OR)
and 95% confidence interval (CI) were calculated for
each study, and the combined OR and 95% CI were cal-
culated for all eligible studies. OR was the proportion of
the exposed population in whom disease has developed
over the proportion of the unexposed population in
whom disease has developed in a case–control study.
The significance of the combined OR was determined by
the Z-test, in which P < 0.05 was considered significant.
Heterogeneity assumption was assessed by the chisquare
based Q test and was regarded to be statistically signifi-
cant if P < 0.10. The potential publication bias was
assessed by Begg’s funnel plot and Egger’s test [42,43].
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